From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease;Von der symptomatischen zur kausalen Therapie? Neue Entwicklungen in der Pharmakotherapie der Alzheimer-Demenz.

Fortschritte der Neurologie-Psychiatrie

Volumn 77, Issue 6, 2009, Pages 326-333

  Franke, A G ^a   Lieb, K ^a   Fellgiebel, A ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMINO ACID RECEPTOR BLOCKING AGENT; AMYLOID; ANTIHISTAMINIC AGENT; CHOLINESTERASE INHIBITOR; NICOTINIC RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NOOTROPIC AGENT; TAU PROTEIN;

ALZHEIMER DISEASE; DRUG ANTAGONISM; HUMAN; IMMUNOTHERAPY; METABOLISM; PATHOLOGY; REVIEW;

ALZHEIMER DISEASE; ALZHEIMER VACCINES; AMYLOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOLINESTERASE INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; HISTAMINE ANTAGONISTS; HUMANS; IMMUNOTHERAPY; NICOTINIC ANTAGONISTS; NOOTROPIC AGENTS; TAU PROTEINS;

EID: 68349153287     PISSN: None     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0028-1109378     Document Type: Review

References (73)